Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR TEST SYSTEMS director Howard T. Slayen reported a sale of 5,700 shares of Common Stock on August 14, 2026 at an average price of $133.0288 per share in an open-market or private transaction. Following this sale, he holds 140,667 shares directly, including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS director Rhea J. Posedel, through a trust, reported selling 5,973 shares of common stock on 2026-08-14 in a sale described as an open market or private transaction at $140.00 per share. After this sale, the trust holds 381,989 indirect shares, and a separate line shows 47,156 direct shares, which include shares subject to unvested restricted stock units.
AWM Investment Company, Inc., a Delaware corporation and investment adviser to several Special Situations funds, reports its beneficial ownership of common stock of AEHR TEST SYSTEMS in this amended Schedule 13G.
AWM reports beneficial ownership of 374,808 shares of AEHR common stock, representing 1.1% of the class, with sole voting and dispositive power over all reported shares and no shared power. The position is held through four funds: 179,296 shares by SSFQP, 51,265 by Cayman, 25,089 by TECH, and 119,158 by TECH II. The filing notes that this represents ownership of 5 percent or less of the outstanding common stock.
Howard Theo Slayen filed a Rule 144 notice for a potential sale of up to 5,700 shares of Charles Schwab Corp. common stock. The filing lists an aggregate market value of $753,910.50 for these shares and notes 32,620,450 shares outstanding, with an approximate sale date of August 14, 2026. It also discloses prior open market purchase dates that correspond to the shares being registered for resale and reports a separate sale of 20,000 shares during the past three months for $2,165,874.71.
Aehr Test Systems insider Rhea Posedel filed a notice to sell common stock under a Form 144. The planned sale covers 5,973 common shares through broker Oppenheimer & Co. Inc., with an aggregate market value of $836,220.00, expected on or about August 14, 2026 on Nasdaq.
The shares were originally acquired on April 20, 2021 as compensation from the issuer. Over the past three months, a separate sale of 8,413 common shares for an aggregate $1,093,690.00 was reported.
AEHR TEST SYSTEMS executive Alberto Salamone reported two open-market sales of company common stock on 2026-08-13, totaling 9,672 shares. Shares were sold at per-share prices of $128.00 and $127.5014. A portion of the reported holdings includes shares subject to unvested restricted stock units.
AEHR filed a Form 144 indicating an intention to sell common stock through Fidelity Brokerage Services LLC. The filing lists 2,000 shares of common stock, with an aggregate value of $273,000.00, to be sold on or after 08/14/2026 on NASDAQ. It also details future common stock from restricted stock vesting granted as compensation, including 47, 248, 795, 478 and 432 shares vesting on specific dates in 2024 and 2025.
Aehr Test Systems President and CEO Gayn Erickson reported two open-market sales of company common stock on August 12, 2026, totaling 40,000 shares held indirectly through a trust. The filing also reports 197,521 shares held directly after the transactions, including shares subject to unvested restricted stock units and unvested restricted shares.
Aehr Test Systems director Rhea J. Posedel reported selling 8,413 shares of common stock on August 12, 2026 at $130 per share through an entity classified as a trust. Following this sale, indirect holdings total 387,962 shares and direct holdings total 47,156 shares, which include shares subject to unvested restricted stock units.
Aehr Test Systems director Geoffrey Scott reported two indirect transactions in Common Stock on 2026-08-12. An entity associated with him made a bona fide gift of 6,731 shares held by a trust to the Scott Family Gift Fund, leaving 23,955 indirect trust shares. His spouse sold 20,000 indirect shares at $131.506 per share, leaving 10,000 indirect shares. Separately, he holds 51,648 shares directly, including shares subject to unvested restricted stock units. The transactions were not reported under a Rule 10b5-1 trading plan.